Researchers test mRNA technology for universal flu vaccine
By Nancy Lapid (Reuters) - An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in
Stay updated with breaking news from Emerging Pathogens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Nancy Lapid (Reuters) - An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in
Animal trials, using the same mRNA technology as successful Covid vaccines, have gone well, scientists say.
By Nancy Lapid (Reuters) - An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in...
'The two beasts of the jungle, the respiratory jungle, flu and Covid, they can be gripped I think by this new technology '
Scientists say they have made a breakthrough designing a vaccine against all 20 known types of flu. It uses the same messenger-ribonucleic-acid (mRNA) technology as successful Covid vaccines. Flu mutates and the current annual jab is updated to ensure the best match for the sort circulating but would probably not protect against new pandemic types. The new vaccine triggered high levels of antibodies, in tests on ferrets and mice, that …